Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Innoviva (INVA) Shares Outstanding (2016 - 2026)

Innoviva filings provide 17 years of Shares Outstanding readings, the most recent being $74.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 19.1% to $74.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.6 million, a 19.1% increase, with the full-year FY2025 number at $74.6 million, up 19.1% from a year prior.
  • Shares Outstanding hit $74.6 million in Q4 2025 for Innoviva, roughly flat from $74.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $101.4 million in Q1 2021 to a low of $69706.0 in Q2 2022.
  • Median Shares Outstanding over the past 5 years was $62.8 million (2024), compared with a mean of $55.6 million.
  • Biggest five-year swings in Shares Outstanding: crashed 99.9% in 2022 and later surged 99900.0% in 2023.
  • Innoviva's Shares Outstanding stood at $69.6 million in 2021, then fell by 0.54% to $69.2 million in 2022, then fell by 8.5% to $63.3 million in 2023, then dropped by 1.01% to $62.7 million in 2024, then increased by 19.1% to $74.6 million in 2025.
  • The last three reported values for Shares Outstanding were $74.6 million (Q4 2025), $74.8 million (Q3 2025), and $63.0 million (Q2 2025) per Business Quant data.